NCT06532773View on ClinicalTrials.gov

Mindfulness Intervention for Sleep Disturbance and Symptom Management in Hematologic Cancer Patients During and After Inpatient Treatment

NANot yet recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

October 31, 2025

Primary Completion Date

June 30, 2029

Study Completion Date

June 30, 2029

Conditions
Hematologic Malignancy
Interventions
BEHAVIORAL

Nite2Day+

Mindfulness-based sleep strategies and cognitive-behavioral symptom coping skills.

Trial Locations (1)

27705

2400 Pratt Street, Durham

Sponsors

Lead Sponsor

Duke University
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Duke University

OTHER

NCT06532773 - Mindfulness Intervention for Sleep Disturbance and Symptom Management in Hematologic Cancer Patients During and After Inpatient Treatment | Biotech Hunter | Biotech Hunter